期刊文献+

抗菌肽Protegrin基因的定点诱变改良研究

Study on Improvement and Site-directed Mutagenesis of Antibacterial Peptide Protegrin
下载PDF
导出
摘要 通过对抗菌肽Protegrin成熟肽的氨基酸组成和作用机理分析,并根据已报道的Protegrin基因序列设计引物,PCR扩增获得定点诱变的突变体基因pg-g,其编码蛋白的末端相对于野生型增加1个非极性氨基酸Gly.利用表达载体pET-28a将突变体基因pg-g转化到大肠杆菌BL21(DE3),IPTG诱导表达后,经SDS-PAGE检测表明目的蛋白得到成功表达.通过对表达产物进行抑菌实验发现,定点突变基因pg-g表达产物对大肠杆菌的抑菌效果有明显提高. According to the reported sequences of the mature peptide of protegrin and its gene,primers were designed to mutate its protein by adding a nonpolar amino acid (Gly) to its end. The mutant type protegrin gene pg-g was amplified by PCR. Then the pg-g gene was ligated with the expression vector pET-28a and transferred into the E. coli BL21 (DE3). After inducing by IPTG and detecting by SDS-PAGE, the target protein was expressed successfully. Results of antibacterial experiment indicated that the expression product of pg-g gene exhibited a higher antibacterial activity on Escherichia coli than its wild type.
出处 《河北师范大学学报(自然科学版)》 CAS 北大核心 2009年第6期810-814,共5页 Journal of Hebei Normal University:Natural Science
基金 河北省自然科学基金(C2009000271) 河北省科技厅攻关项目(06220114D-3)
关键词 抗菌肽 PROTEGRIN 定点诱变 拼接PCR 抑菌实验 antibacterial peptide protegrin site-directed mutagenesis splices PCR antibacterial experiment
  • 相关文献

参考文献19

  • 1GARCIA-RODRIGUEZ J A,JONES R N. Mystic Programme Study Group Antimicrobial Resistance in Gram-negative Isolates from European Intensive Care Units:Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme [J]. Journal of Chemotherapy,2002,14:25.
  • 2STEINBERG D A, HURST M A,FUJII C A, et al. Protegrin-1 :A Broad-spectrum, Rapidly Microbicidal Peptide with in vivo Activity [ J ]. Antimicrobial Agents and Chemotherapy, 1997,41 (8) : 1738-1742.
  • 3QU X D,HARWIG S S,SHAFER W M, et al. Protegrin Structure and Activity Against Nesseria Gonorrhoeae [J ]. Infectinon and Immunity, 1997,65 (2) : 636-639.
  • 4QU X D, HARWIG S S L, OREN A, et al. Susceptibiliry of Nei,s, seria Gonorrhoeae to Protegrins [J ]. Infection and Immunity, 1996,64(4) : 1240-1245.
  • 5YASIN B, HARWIG S S, LEHRER R I, et al. Susceptibility of Chlamydia Trachomatics to Protegrins and Defensins [J ]. Infection and Immunity,1996,64(3) :709-713.
  • 6KATE F,PATRICIA A T, ROBERT I L,et al. Haemophilus Ducreyi is Susceptible to Protegrin [J ]. Antimicrobial Agents and Chemotherapy, 1998,42 ( 10) : 2690-2693.
  • 7BULET P,STOCKLIN R, MENIN L. Anti-microbial Peptides: From Invertebrates to Vertebrates [J ]. Immunol Rev, 2004, 198 : 169.
  • 8OSTBERG N, KAZNESSIS Y. Protegrin Structure-activity Relationships: Using Homology Models of Synthetic Sequences to Determine Structural Characteristics Important for Activity [ J ]. Peptides, 2005,26 (2) : 197-206.
  • 9CHEN J,FALLA T J, LIU H, et al. Development of Protegrins for the Treatment and Prevention of Oral Mucositis. Structureactivity Relationships of Synthetic Protegrin Analogues [J ]. Biopolymers, 2000,55 ( 1 ) ; 88-98.
  • 10STEVEN A M, jAMES P T. Design of Gram-negative Selective Antimicrobial Peptides [J ]. Biochemistry, 2001,40 (19):5777-5785.

二级参考文献102

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部